Biodexa Total Assets from 2010 to 2024

BDRX Stock

4.93 0.13 2.71%

Biodexa Pharmaceticals Total Assets yearly trend continues to be fairly stable with very little volatility. Total Assets are likely to outpace its year average in 2024. Total Assets is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. View All Fundamentals

Total Assets

First Reported

2013-09-30

Previous Quarter

14 M

Current Value

14 M

Quarterly Volatility

19.7 M

Yuan Drop

Covid

Check Biodexa Pharmaceticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Biodexa Pharmaceticals' main balance sheet or income statement drivers, such as Depreciation And Amortization of 268.9 K, Selling General Administrative of 3.9 M or Other Operating Expenses of 11.7 M, as well as many indicators such as Price To Sales Ratio of 4.15, Dividend Yield of 0.0 or PTB Ratio of 0.34. Biodexa financial statements analysis is a perfect complement when working with Biodexa Pharmaceticals Valuation or Volatility modules.

Check out the analysis of Biodexa Pharmaceticals Correlation against competitors.

For more information on how to buy Biodexa Stock please use our How to Invest in Biodexa Pharmaceticals guide.

Latest Biodexa Pharmaceticals' Total Assets Growth Pattern

Below is the plot of the Total Assets of Biodexa Pharmaceticals over the last few years. Total assets refers to the total amount of Biodexa Pharmaceticals assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Biodexa Pharmaceticals books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. It is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. Biodexa Pharmaceticals' Total Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Biodexa Pharmaceticals' overall financial position and show how it may be relating to other accounts over time.

View

Last Reported 10.54 M

10 Years Trend

Very volatile

Compare to Others All Fundamentals

Total Assets

Timeline

Biodexa Total Assets Regression Statistics

	Arithmetic Mean	22,635,547
	Geometric Mean	12,910,878
	Coefficient Of Variation	95.10
	Mean Deviation	17,911,236
	Median	12,913,000
	Standard Deviation	21,526,120
	Sample Variance	463.4T
	Range	61.8M
	R-Value	0.01
	Mean Square Error	499T
	R-Squared	0.0001
	Significance	0.97
	Slope	54,937
	Total Sum of Squares	6487.2T

Biodexa Total Assets History

	2024	20.9 M
	2023	10.5 M
	2022	5.5 M
	2021	12.9 M
	2020	9.8 M
	2019	30.9 M
	2018	20.4 M

Other Fundumenentals of Biodexa Pharmaceticals

Intangibles To Total Assets

Biodexa Pharmaceticals Total Assets component correlations

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Accounts Payable	Total Liab	Total Current Assets	Intangible Assets	Net Receivables	Short Term Debt	Common Stock	Net Tangible Assets	Net Invested Capital	Short Long Term Debt	Capital Stock	Net Working Capital	Property Plant Equipment	Current Deferred Revenue
Total Assets		0.98	-0.73	0.1	0.67	0.71	0.89	0.94	0.66	-0.38	-0.25	-0.29	0.37	0.34	-0.25	0.23	0.36	-0.17
Total Stockholder Equity	0.98		-0.8	0.09	0.62	0.59	0.92	0.9	0.59	-0.43	-0.3	-0.27	0.35	0.33	-0.3	0.29	0.33	-0.25
Net Debt	-0.73	-0.8		-0.04	-0.29	-0.2	-0.94	-0.55	-0.24	0.4	0.14	0.08	-0.09	-0.08	0.14	-0.14	-0.05	0.06
Retained Earnings	0.1	0.09	-0.04		0.1	0.33	0.02	0.18	0.0	0.83	-0.69	-0.69	0.85	0.83	-0.68	0.63	0.82	-0.61
Accounts Payable	0.67	0.62	-0.29	0.1		0.73	0.52	0.64	0.42	-0.12	-0.35	-0.35	0.46	0.44	-0.35	0.33	0.45	-0.31
Total Liab	0.71	0.59	-0.2	0.33	0.73		0.4	0.79	0.68	0.06	-0.31	-0.38	0.53	0.49	-0.3	0.25	0.53	-0.19
Total Current Assets	0.89	0.92	-0.94	0.02	0.52	0.4		0.71	0.45	-0.45	-0.2	-0.18	0.21	0.18	-0.2	0.2	0.17	-0.12
Intangible Assets	0.94	0.9	-0.55	0.18	0.64	0.79	0.71		0.59	-0.3	-0.29	-0.32	0.44	0.42	-0.28	0.25	0.44	-0.22
Net Receivables	0.66	0.59	-0.24	0.0	0.42	0.68	0.45	0.59		-0.24	0.0	-0.05	0.16	0.14	0.0	-0.03	0.19	0.03
Short Term Debt	-0.38	-0.43	0.4	0.83	-0.12	0.06	-0.45	-0.3	-0.24		-0.43	-0.48	0.59	0.57	-0.42	0.37	0.58	-0.35
Common Stock	-0.25	-0.3	0.14	-0.69	-0.35	-0.31	-0.2	-0.29	0.0	-0.43		0.78	-0.8	-0.84	1.0	-0.96	-0.65	0.87
Net Tangible Assets	-0.29	-0.27	0.08	-0.69	-0.35	-0.38	-0.18	-0.32	-0.05	-0.48	0.78		-0.77	-0.89	0.78	-0.63	-0.61	0.69
Net Invested Capital	0.37	0.35	-0.09	0.85	0.46	0.53	0.21	0.44	0.16	0.59	-0.8	-0.77		0.94	-0.79	0.75	0.96	-0.64
Short Long Term Debt	0.34	0.33	-0.08	0.83	0.44	0.49	0.18	0.42	0.14	0.57	-0.84	-0.89	0.94		-0.83	0.71	0.85	-0.73
Capital Stock	-0.25	-0.3	0.14	-0.68	-0.35	-0.3	-0.2	-0.28	0.0	-0.42	1.0	0.78	-0.79	-0.83		-0.96	-0.64	0.87
Net Working Capital	0.23	0.29	-0.14	0.63	0.33	0.25	0.2	0.25	-0.03	0.37	-0.96	-0.63	0.75	0.71	-0.96		0.64	-0.84
Property Plant Equipment	0.36	0.33	-0.05	0.82	0.45	0.53	0.17	0.44	0.19	0.58	-0.65	-0.61	0.96	0.85	-0.64	0.64		-0.57
Current Deferred Revenue	-0.17	-0.25	0.06	-0.61	-0.31	-0.19	-0.12	-0.22	0.03	-0.35	0.87	0.69	-0.64	-0.73	0.87	-0.84	-0.57

Click cells to compare fundamentals

About Biodexa Pharmaceticals Financial Statements

Biodexa Pharmaceticals investors use historical fundamental indicators, such as Biodexa Pharmaceticals' Total Assets, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Biodexa Pharmaceticals. Please read more on our technical analysis and fundamental analysis pages.

	Last Reported	Projected for Next Year
Total Assets	10.5 M	20.9 M
Intangibles To Total Assets	0.28	0.26

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

ESRT	Empire State Realty
C	Citigroup
C	Citigroup

Additional Tools for Biodexa Stock Analysis

When running Biodexa Pharmaceticals' price analysis, check to measure Biodexa Pharmaceticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biodexa Pharmaceticals is operating at the current time. Most of Biodexa Pharmaceticals' value examination focuses on studying past and present price action to predict the probability of Biodexa Pharmaceticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biodexa Pharmaceticals' price. Additionally, you may evaluate how the addition of Biodexa Pharmaceticals to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC